You are here
Medicine shortages: Information for sponsors (suppliers)
This web page provides guidance and other resources for sponsors about mandatory reporting of medicine shortages in Australia
Mandatory reporting of medicine shortages
Sponsors of ‘reportable medicines’ must notify the TGA when the medicine is in shortage at a particular time or being discontinued.
A medicine shortage occurs when the supply of a medicine is not likely to meet the normal or projected consumer demand within Australia at any point during the next 6 months. A discontinuation is a permanent shortage.
The legal definition of a medicine shortage:
There is a shortage of a medicine in Australia at a particular time if at any time in the six months after that particular time, the supply of that medicine in Australia will not, or will not be likely to, meet the demand for the medicine for all of the patients in Australia who take, or who may need to take, the medicine.
Reportable medicines
Reportable medicines include:
- registered Schedule 4 (Prescription Medicine) medicines
- registered Schedule 8 (Controlled Drug) medicines
- over-the-counter medicines included in the Therapeutic Goods (Reportable Medicines) Determination
If you are a sponsor of a reportable medicine, you must report all shortages and discontinuations affecting the medicine to us within mandated timeframes.
Reporting timeframes and shortage impact ratings
The timeframe in which you must report a new shortage or discontinuation to the TGA depends on its shortage impact rating.
When you becomes aware of a medicine shortage, you must assess the shortage impact rating to determine how quickly you must notify the TGA.
- Shortages with a critical shortage impact rating at that time must be reported as soon as possible, but no later than 2 working days after discovering the shortage.
- All other shortages must be reported within 10 working days.
Determining impact rating
- Decision tree – What is the shortage rating of my medicine shortage and do I need to report it to the TGA?
Interactive tool to help you identify the rating of your shortage and the associated mandatory reporting timeframes.
Reporting changes to the period of a medicine shortage and resolution of a medicine shortage
You must report any change to the shortage duration or end date to the TGA. You must notify us when the shortage has resolved. Reporting timeframes are in-line with the initial impact rating.
- For medicines first notified with critical shortage impact rating the notification must occur as soon as possible , but no later than 2 working days after discovering the change to the shortage period or end date
- In any other case - before the end of 10 working days beginning on the first day the person knows, or ought reasonably to have known, of the change to the period or end date.
You will need to vary the notification form for your submitted shortage to notify us of these changes. You are able to vary your submitted notification after we have assessed it and moved it into the ‘Medicine Shortage’ list. See our guidance on electronic notification for further information.
Reporting medicine shortages links
- Reporting medicine shortages and discontinuations in Australia – Guidance for sponsors
Guidance for sponsors and suppliers describing compliance obligations, mandatory reporting requirements and when to report a medicine shortage or discontinuation to the TGA. - Medicine shortages/discontinuations – Electronic notification form: user guide
Guidance on submitting a medicine shortage notification form, using the TGA Business Services (TBS) portal.
The Medicine Shortage Notification form in TBS was updated on Tuesday 1 June 2021.
This Quick Reference Guide will help you understand the changes and give you an overview of the differences you will see when submitting Medicine Shortage notifications.
Medicine shortages educational materials
Mandatory Reporting Scheme
- Medicine Shortage Reports Database
The public database of the medicine shortages and discontinuations reported to the TGA - Medicine Shortages in Australia: Reporting obligations and the TGA's compliance framework
Details about TGA’s mandatory medicine shortages reporting scheme and approach to compliance - Management and communication of medicine shortages and discontinuations in Australia - The medicine shortages information initiative
High-level historical account of changes to how medicines shortages and discontinuations are managed in Australia
Supplying alternative medicines during a shortage under section 19A
During a shortage, sponsors can apply to supply alternative medicines not included in the Australian Register of Therapeutic Goods under section 19A of the Therapeutic Goods Act 1989.
- Supplying medicines during a shortage under section 19A
Information on applying to import and supply a medicine not included in the Australian Register of Therapeutic Goods - Database of section 19A approvals to import and supply medicines to address medicine shortages
The public database detailing all medicines approved for import and supply during a shortage
Registering prescription medicines to manage shortages
- Registration of prescription medicines to manage shortages
The TGA welcomes applications to register new generics of medicines included in the Australian Register of Therapeutic Goods (ARTG) that are in long-term shortage.
Alerts
You can subscribe to the medicine shortages alert service to receive email or RSS feed notifications of new and updated medicine shortages information.
This webpage on the TGA website was printed on 21 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/resource/guidance/medicine-shortages-information-sponsors-suppliers